biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by vitreumon Oct 30, 2015 12:01pm

198 Views

Post# 24243594

RE:who is doing all the selling ?

day trader/broker with haywood securities is doing the buying/selling to make a nickel on each trade, Complete azz-whole scumbag. Original selling was coming from a swiss fund where the partners went to war wirth each other, decided to sell certain stocks, including BTI, and go their separate ways.
look for their first licensing agreement with one of four pharmcos by the end of november, just informed speculation on my part

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity